4-METHYLPYRIDINE-2,6-DIAMINE, 95%, 250mg

S-(Benzo[d]thiazol-2-yl)-N,N-dicyclohexylthiohydroxylamine, 95.0%, 10g

2-[4-(Pyrimidin-2-yl)piperazin-1-yl]pyrimidine, 95%, 1g

6-mercapto-1-(2-methoxyphenyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one, 95.0%, 500mg

2',5'-DIDEOXYADENOSINE, 95%, 25mg

4,6-Dibromo-2,3-dimethylaniline, 1g

2-(6-Methylpyridin-2-yl)acetonitrile, 95+%, 500mg

3-(4-METHOXYPHENYL)PYRROLIDINE OXALATE, 95.0%, 1g

Methyl 3-(2-(benzyloxy)-5-bromophenyl)-3-phenylpropanoate, 98%, 100mg

Bortezomib>98.0%(HPLC)10mg

2-Morpholinoethanesulfonic acid, 98%, 1kg

1,1,2,2-Tetrakis(4-(1H-imidazol-1-yl)phenyl)ethene, 97%, 25g

Colonne capillaire GC ROTI®Cap-1, 10 m, 0,32 mm, 1,00 µm, 1 pièce(s)